HomeREGULATORY
REGULATORY

Benralizumab, Olaparib, Keytruda’s Urothelial Carcinoma Use Up for MHLW Panel Review/Report on Nov. 24
(Nov.13.2017)

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will review on November 24 whether to recommend approval for the asthma drug benralizumab, which was originated by Kyowa Hakko Kirin and licensed to AstraZeneca ...
(LOG IN FOR FULL STORY)